Chemours CC Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 15.5%-4.2pp | 19.8%-1.7pp | 21.5%-2.3pp | 23.8%+2.0pp | |
| Net margin | -6.6%-7.9pp | 1.2%+5.1pp | -3.9%-12.4pp | 8.5%-1.1pp | |
| EBITDA margin | 5.7%-5.8pp | 11.5%+8.2pp | 3.3%-14.3pp | 17.6%-1.0pp | |
| Returns | |||||
| Return on equity | -94%-105pp | 11%+36.9pp | -25.9%-78.8pp | 52.8%-11.5pp | |
| Return on assets | -5.2%-6.1pp | 0.9%+3.9pp | -3%-10.6pp | 7.6%-0.7pp | |
| Return on invested capital | -0.2%-6.2pp | 6%+8.8pp | -2.8%-21.3pp | 18.5%-1.5pp | |
| Efficiency | |||||
| Asset turnover | 0.8×0.0× | 0.7×0.0× | 0.8×-0.1× | 0.9×0.0× | |
| Inventory turnover | 3.2×-0.1× | 3.3×-0.2× | 3.5×-0.7× | 4.1×-0.7× | |
| Liquidity | |||||
| Current ratio | 1.8×+0.1× | 1.7×+0.1× | 1.5×-0.2× | 1.7×-0.1× | |
| Quick ratio | 0.8×0.0× | 0.9×-0.1× | 1×0.0× | 1×-0.3× | |
| Cash ratio | 0.4×0.0× | 0.4×-0.1× | 0.5×-0.1× | 0.6×-0.2× | |
| Leverage | |||||
| Debt-to-equity | 17.7×+10.0× | 7.7×+1.7× | 6×+2.5× | 3.6×-0.2× | |
| Debt-to-assets | 0.6×0.0× | 0.6×+0.1× | 0.5×0.0× | 0.5×0.0× | |
| Net debt / EBITDA | 11.3×+5.8× | 5.6×-10.3× | 15.9×+13.5× | 2.4×+0.2× | |
| Interest coverage | -0×-1.4× | 1.4×+1.9× | -0.5×-6.1× | 5.6×+0.9× | |
| Valuation | |||||
| Market capitalization | $1.77B-30.0% | $2.53B-46.1% | $4.69B+2.0% | $4.59B-14.4% | |
| Enterprise value | $5.53B-11.1% | $6.22B-20.6% | $7.84B+5.5% | $7.43B-6.8% | |
| Price / sales | 0.3×-0.1× | 0.4×-0.3× | 0.8×+0.1× | 0.7×-0.2× | |
| Price / book | 7.1×+2.6× | 4.4×-2.1× | 6.5×+2.3× | 4.2×-0.8× | |
| EV / EBITDA | 16.7×+7.3× | 9.4×-30.0× | 39.4×+33.2× | 6.2×-0.6× | |
| EV / sales | 1×-0.1× | 1.1×-0.2× | 1.3×+0.2× | 1.1×-0.2× | |
| Earnings yield | -21.8%-24.7pp | 2.8%+7.9pp | -5.1%-17.6pp | 12.6%+1.2pp | |
| Dividend yield | 4.4%-1.4pp | 5.9%+2.7pp | 3.2%-0.2pp | 3.4%+0.3pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Chemours's ratios come from?
- Every ratio is computed from Chemours's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.